These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35168891)

  • 1. Why Do Adults Value EQ-5D-Y-3L Health States Differently for Themselves Than for Children and Adolescents: A Think-Aloud Study.
    Reckers-Droog V; Karimi M; Lipman S; Verstraete J
    Value Health; 2022 Jul; 25(7):1174-1184. PubMed ID: 35168891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Adult and Adolescent Preferences Toward EQ-5D-Y-3L Health States.
    Prevolnik Rupel V; Ramos-Goñi JM; Ogorevc M; Kreimeier S; Ludwig K; Greiner W
    Value Health; 2021 Sep; 24(9):1350-1359. PubMed ID: 34452716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Like holding the axe on who should live or not': adolescents' and adults' perceptions of valuing children's health states using a standardised valuation protocol for the EQ-5D-Y-3L.
    Åström M; Conte H; Berg J; Burström K
    Qual Life Res; 2022 Jul; 31(7):2133-2142. PubMed ID: 35201557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states.
    Lipman SA; Reckers-Droog VT; Karimi M; Jakubczyk M; Attema AE
    Eur J Health Econ; 2021 Dec; 22(9):1507-1518. PubMed ID: 34611793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?
    Ramos-Goñi JM; Estévez-Carrillo A; Rivero-Arias O; Rowen D; Mott D; Shah K; Oppe M
    Value Health; 2022 Jul; 25(7):1196-1204. PubMed ID: 35379562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.
    Fitriana TS; Roudijk B; Purba FD; Busschbach JJV; Stolk E
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):157-167. PubMed ID: 36348155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Think of the Children: A Discussion of the Rationale for and Implications of the Perspective Used for EQ-5D-Y Health State Valuation.
    Lipman SA; Reckers-Droog VT; Kreimeier S
    Value Health; 2021 Jul; 24(7):976-982. PubMed ID: 34243841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value Set for the EQ-5D-Y-3L in Hungary.
    Rencz F; Ruzsa G; Bató A; Yang Z; Finch AP; Brodszky V
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):205-215. PubMed ID: 36123448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valuing child and adolescent health: a qualitative study on different perspectives and priorities taken by the adult general public.
    Powell PA; Rowen D; Rivero-Arias O; Tsuchiya A; Brazier JE
    Health Qual Life Outcomes; 2021 Sep; 19(1):222. PubMed ID: 34556133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Valuation Protocol for the EQ-5D-Y-3L.
    Ramos-Goñi JM; Oppe M; Stolk E; Shah K; Kreimeier S; Rivero-Arias O; Devlin N
    Pharmacoeconomics; 2020 Jul; 38(7):653-663. PubMed ID: 32297224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In a Child's Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives.
    Lipman SA; Essers BAB; Finch AP; Sajjad A; Stalmeier PFM; Roudijk B
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):181-192. PubMed ID: 36255560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
    Mott DJ; Shah KK; Ramos-Goñi JM; Devlin NJ; Rivero-Arias O
    Med Decis Making; 2021 Jul; 41(5):584-596. PubMed ID: 33733920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EQ-5D-Y Value Set for Slovenia.
    Prevolnik Rupel V; Ogorevc M;
    Pharmacoeconomics; 2021 Apr; 39(4):463-471. PubMed ID: 33565048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test-Retest Reliability of EQ-5D-Y-3L Best-Worst Scaling Choices of Adolescents and Adults.
    Xiong X; Dalziel K; Huang L; Rivero-Arias O
    Value Health; 2023 Jan; 26(1):50-54. PubMed ID: 35970707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents.
    Åström M; Rolfson O; Burström K
    Appl Health Econ Health Policy; 2022 May; 20(3):383-393. PubMed ID: 35083734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An EQ-5D-Y-3L Value Set for Belgium.
    Dewilde S; Roudijk B; Tollenaar NH; Ramos-Goñi JM
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):169-180. PubMed ID: 36316544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EQ-5D-Y Value Set for Germany.
    Kreimeier S; Mott D; Ludwig K; Greiner W;
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):217-229. PubMed ID: 35604633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expect Nothing: The (Lack of) Influence of Subjective Life Expectancy on Valuation of Child Health States.
    Lipman SA
    Front Health Serv; 2022; 2():803109. PubMed ID: 36925864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population health status based on the EQ-5D-Y-3L among adolescents in Sweden: Results by sociodemographic factors and self-reported comorbidity.
    Åström M; Persson C; Lindén-Boström M; Rolfson O; Burström K
    Qual Life Res; 2018 Nov; 27(11):2859-2871. PubMed ID: 30196340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.